| Dr Richard David Levin, MD | |
|
21355 E Dixie Hwy, Suite 102, Aventura, FL 33180-1238 | |
| (305) 932-4444 | |
| Not Available |
| Full Name | Dr Richard David Levin |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 21355 E Dixie Hwy, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114937067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME 71204 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Entity Name | Urodocs Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841279296 PECOS PAC ID: 6709962079 Enrollment ID: O20110419000935 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.
Array BioPharma Inc. today announced positive dose-escalation/expansion data for its novel, small molecule dual p38/Tie2 inhibitor, ARRY-614.
Anita Willis says the social worker offered her a painful choice: She could either leave the San Jose, Calif., nursing home where she'd spent a month recovering from a stroke — or come up with $336 a day to stay on.
Illumina, Inc. today announced that it has delivered Hermann Hauser's genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina's individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard David Levin, MD 21355 E Dixie Hwy, Suite 102, Aventura, FL 33180-1238 Ph: (305) 932-4444 | Dr Richard David Levin, MD 21355 E Dixie Hwy, Suite 102, Aventura, FL 33180-1238 Ph: (305) 932-4444 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.
Array BioPharma Inc. today announced positive dose-escalation/expansion data for its novel, small molecule dual p38/Tie2 inhibitor, ARRY-614.
Anita Willis says the social worker offered her a painful choice: She could either leave the San Jose, Calif., nursing home where she'd spent a month recovering from a stroke — or come up with $336 a day to stay on.
Illumina, Inc. today announced that it has delivered Hermann Hauser's genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina's individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics.
› Verified 4 days ago
Boris V Klopukh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 201, Aventura, FL 33180 Phone: 305-534-4747 Fax: 305-937-7726 | |
Giridhar S Talluri, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd Ste 403, Aventura, FL 33180 Phone: 305-918-0742 Fax: 305-918-0787 | |
Jonathan L Silberstein, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 20801 Biscayne Blvd Ste 203, Aventura, FL 33180 Phone: 305-682-2580 Fax: 305-705-1677 | |
Floyd E Seskin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct, Suite 101, Aventura, FL 33180 Phone: 305-792-6905 Fax: 305-792-6908 | |
Mark B Weitzenfeld, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 401, Aventura, FL 33180 Phone: 305-933-1772 Fax: 305-675-2788 | |
Dr. Arnon Krongrad, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 20900 Ne 30th Ave, Suite 207, Aventura, FL 33180 Phone: 305-936-0474 Fax: 305-936-0498 |